ICIG will acquire Novartis drug plant | Chemical & Engineering News
Volume 94 Issue 9 | p. 17 | Concentrates
Issue Date: February 29, 2016

ICIG will acquire Novartis drug plant

Department: Business
Keywords: chemicals, antibiotics, fermentation, pharmaceutical chemicals

International Chemical Investors Group has agreed to acquire a Novartis enzyme-based fermentation products plant in Frankfurt. With the purchase, ICIG will become a major supplier of 7-aminocephalosporanic acid, an antibiotic intermediate. ICIG also plans to use the intermediate at its Latina, Italy, antibiotics plant. Since its inception in 2004, ICIG has acquired 24 chemical and drug businesses from major companies.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment